US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Gyre Therapeutics Inc (GYRE)
Gyre Therapeutics Inc (GYRE) ニュース

GYRE

Gyre Therapeutics (GYRE)

Gyre Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GYRE

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/31	05 : 06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/31	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/31	05 : 05	GlobeNewswire Inc.	Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/31	05 : 02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/29	05 : 05	GlobeNewswire Inc.	Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/14	05 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/10	05 : 10	GlobeNewswire Inc.	Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/10	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/05/08	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/03/26	19 : 00	GlobeNewswire Inc.	Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	NASDAQ:GYRE	Gyre Therapeutics Inc
2024/03/21	20 : 00	GlobeNewswire Inc.	Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/12/15	23 : 04	PR Newswire (US)	Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/13	21 : 00	GlobeNewswire Inc.	Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/03	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/02	06 : 18	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GYRE	Gyre Therapeutics Inc
2023/11/02	05 : 58	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:GYRE	Gyre Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:GYRE

1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約